Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Protagenic Therapeutics, Inc.\new | atrn20170522_8k.htm |
Exhibit 16.1
May 22, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Protagenic Therapeutics, Inc. under Item 4.01 of its Form 8-K dated May 18, 2017. We agree with the statements concerning our Firm contained in such Form 8-K; we are not in a position to agree or disagree with other statements of Protagenic Therapeutics, Inc. contained therein.
Very truly yours,
/s/ Marcum LLP
Marcum LLP
New York, NY